tiprankstipranks
Advertisement
Advertisement
Aura Biosciences reports Q1 results, appoints new CEO
PremiumCompany AnnouncementsAura Biosciences reports Q1 results, appoints new CEO
2M ago
Aura Biosciences Completes Major Underwritten Equity Financing
Premium
Company Announcements
Aura Biosciences Completes Major Underwritten Equity Financing
3M ago
Aura Biosciences Announces Stock Repurchase Agreement with Shareholder
Premium
Company Announcements
Aura Biosciences Announces Stock Repurchase Agreement with Shareholder
3M ago
Aura Biosciences price target raised to $15 from $13 at Evercore ISI
PremiumThe FlyAura Biosciences price target raised to $15 from $13 at Evercore ISI
3M ago
Aura Biosciences: Strong Cash Runway and Accelerating bel-sar Clinical Momentum Support Buy Rating
Premium
Ratings
Aura Biosciences: Strong Cash Runway and Accelerating bel-sar Clinical Momentum Support Buy Rating
4M ago
Aura Biosciences Reports 2025 Results, Advances Bel-Sar Pipeline
Premium
Company Announcements
Aura Biosciences Reports 2025 Results, Advances Bel-Sar Pipeline
4M ago
Buy Rating on Aura Biosciences Inc. Driven by Promising Pipeline and Strategic Expansion in Ocular Oncology
PremiumRatingsBuy Rating on Aura Biosciences Inc. Driven by Promising Pipeline and Strategic Expansion in Ocular Oncology
8M ago
Aura Biosciences Reports Q3 2025 Financial Results
Premium
Company Announcements
Aura Biosciences Reports Q3 2025 Financial Results
8M ago
Positive Outlook for Aura Biosciences Inc: Strong Financial Position and Promising Clinical Progress Justify Buy Rating
Premium
Ratings
Positive Outlook for Aura Biosciences Inc: Strong Financial Position and Promising Clinical Progress Justify Buy Rating
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100